Multiple Sclerosis Research Repository

1. “Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis-a review of population-specific evidence from randomized clinical trials”: Antonios Bayas et al

-the potential of these drugs to reduce relapse-independent progression remains unclear

-The authors suggested that anti-inflammatory DMTs have no substantial effect on relapse-independent disability progression in SPMS without a distinct inflammatory phenotype